Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression
暂无分享,去创建一个
Yun-Ju Chen | Wei‐Chien Huang | C. Yen | Chien-Yi Ho | Shu-Hui Liu | Jhen-Yu Chen | Ching‐Chow Chen | Liang‐Chih Liu | Wen-Shu Chen
[1] Yun-Ju Chen,et al. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3 , 2015, Oncotarget.
[2] Yun-Ju Chen,et al. Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6 , 2015, Oncotarget.
[3] S. Thorgeirsson,et al. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. , 2015, Journal of hepatology.
[4] M. Hung,et al. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin , 2015, Oncotarget.
[5] M. Bouchard,et al. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. , 2015, World journal of gastroenterology.
[6] Hui-Xiong Xu,et al. The Role of MicroRNAs in Hepatocellular Carcinoma , 2018, Journal of Cancer.
[7] S. Arora,et al. Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance , 2015, BioMed research international.
[8] H. Yao,et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.
[9] Meng Li,et al. Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β , 2015, Cancer Prevention Research.
[10] J. Qian,et al. MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer. , 2015, International journal of clinical and experimental medicine.
[11] Ye Zhang,et al. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1 , 2015, Tumor Biology.
[12] George A Calin,et al. A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients , 2014, Clinical Cancer Research.
[13] J. Cheong,et al. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression. , 2014, Cancer letters.
[14] E. Azhar,et al. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. , 2014, World journal of gastroenterology.
[15] Hao Zhou,et al. Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin. , 2014, Cellular signalling.
[16] W. N. Chen,et al. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. , 2014, World journal of gastroenterology.
[17] Yuepeng Sun,et al. [HBx silencing by shRNA down-regulates MMP-2 expression in human hepatocellular carcinoma cell HepG2.2.15]. , 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
[18] Huifang Liang,et al. HBx Protein Promotes Oval Cell Proliferation by Up-Regulation of Cyclin D1 via Activation of the MEK/ERK and PI3K/Akt Pathways , 2014, International journal of molecular sciences.
[19] Chia-Hung Chen,et al. Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells , 2014, BioMed research international.
[20] Sheng-Chieh Hsu,et al. BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib , 2013, PloS one.
[21] Chia-Hung Chen,et al. Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors , 2013, BMC Genomics.
[22] P. S. Mitchell,et al. Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity , 2013, Molecular Cancer Research.
[23] J. Kuang,et al. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein]. , 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[24] Xianxin Li,et al. Identification of miR-7 as an oncogene in renal cell carcinoma , 2013, Journal of Molecular Histology.
[25] Tzung-Chi Huang,et al. Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells , 2013, Evidence-based complementary and alternative medicine : eCAM.
[26] M. Hung,et al. Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis. , 2013, American journal of translational research.
[27] Vijay Kumar,et al. The HBx protein of hepatitis B virus confers resistance against nucleolar stress and anti‐cancer drug‐induced p53 expression , 2013, FEBS letters.
[28] C. Tu,et al. Lapatinib , 2013, Reactions Weekly.
[29] L. Rybak,et al. Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway , 2012, PloS one.
[30] M. Hendrix,et al. Maspin: molecular mechanisms and therapeutic implications , 2012, Cancer and Metastasis Reviews.
[31] S. Nair,et al. Emerging roles for modulation of microRNA signatures in cancer chemoprevention. , 2012, Current cancer drug targets.
[32] M. Hung,et al. Hepatitis B virus X protein induces IKKα nuclear translocation via Akt‐Dependent phosphorylation to promote the motility of hepatocarcinoma cells , 2012, Journal of cellular physiology.
[33] Vijay Kumar,et al. Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation , 2012, The FEBS journal.
[34] Hong Zhang,et al. Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α. , 2012, Chinese medical journal.
[35] J. Ruland. Return to homeostasis: downregulation of NF-κB responses , 2011, Nature Immunology.
[36] I. Jacobson,et al. Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis , 2011, Nature Reviews Gastroenterology &Hepatology.
[37] M. Kew. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.
[38] Yan He,et al. Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells , 2010, Medical oncology.
[39] C. Chao,et al. Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. , 2010, Biochemical pharmacology.
[40] B. Bartosch. Hepatitis B and C Viruses and Hepatocellular Carcinoma , 2010, Viruses.
[41] Jian Shi,et al. High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancer , 2010, International journal of cancer.
[42] J. Davie,et al. H3 phosphorylation: dual role in mitosis and interphase. , 2009, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[43] Shuhan Sun,et al. Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.
[44] K. Lee,et al. Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] M. Karin,et al. NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.
[46] C. Loffredo,et al. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. , 2008, Mutation research.
[47] A. Nakagawara,et al. ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin , 2008, Oncogene.
[48] P. Allavena,et al. Pathways connecting inflammation and cancer. , 2008, Current opinion in genetics & development.
[49] J. Sung,et al. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. , 2007, Cancer letters.
[50] M. Hung,et al. Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB , 2007 .
[51] David A. Cheresh,et al. Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.
[52] F. Real,et al. Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.
[53] Claus Scheidereit,et al. IκB kinase complexes: gateways to NF-κB activation and transcription , 2006, Oncogene.
[54] Michael Karin,et al. Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.
[55] D. Min,et al. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1 , 2005, Oncogene.
[56] Hung-Jen Liu,et al. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. , 2005, Journal of hepatology.
[57] K. McGlynn,et al. Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.
[58] Z. Weng,et al. Identification of conserved structural features at sequentially degenerate locations in transcription factor binding sites. , 2005, Genome informatics. International Conference on Genome Informatics.
[59] Tae-Wook Chung,et al. Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potential , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] Victor G Corces,et al. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.
[61] Wyeth W. Wasserman,et al. JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..
[62] R. Gaynor,et al. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.
[63] C. Martínez-A,et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. , 2002, The Journal of clinical investigation.
[64] F. Rösel,et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. , 2002, Biochemical and biophysical research communications.
[65] S. Sheng,et al. Maspin sensitizes breast carcinoma cells to induced apoptosis , 2002, Oncogene.
[66] Hong Duan,et al. Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.
[67] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[68] O. Volpert,et al. Maspin is an angiogenesis inhibitor , 2000, Nature Medicine.
[69] Tatsuhiko Tsunoda,et al. Estimating transcription factor bindability on DNA , 1999, Bioinform..
[70] A. Graessmann,et al. The Hepatitis B Virus HBx Protein Inhibits Caspase 3 Activity* , 1998, The Journal of Biological Chemistry.
[71] M. Hendrix,et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.